No immediate trading catalyst — board additions and warrant consolidation are routine governance. Monitor upcoming clinical data readouts or pipeline updates for the next material event.
Price Chart
Executive Summary
Agomab announced the appointments of Marino Garcia and Dr. Naimish Patel to its Board of Directors, approved at a Special and Extraordinary General Shareholders' Meeting on September 11, 2026. Shareholders also approved the consolidation and split adjustment of outstanding pre-IPO warrants to align with the February 2026 IPO share split. This is a routine governance filing with no material financial data or operational catalysts — board additions and warrant housekeeping are neutral events for a clinical-stage biotech.
Key Facts
- Shareholders approved the appointments of Marino Garcia and Dr. Naimish Patel as non-executive Board members.
- Shareholders approved the consolidation and split adjustment of outstanding pre-IPO warrants to align with the February 2026 IPO share split.
- The Special and Extraordinary General Shareholders' Meeting was held on September 11, 2026.
- All resolutions submitted for consideration at the meeting were approved.
Financial Impact
No financial figures disclosed; warrant consolidation is a mechanical adjustment with no cash impact.
Risk Factors
- No material risks identified from this filing; standard clinical-stage biotech risks apply per the company's forward-looking statements.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (AGMB) — Batch item 1 | 0001104659-26-107117 |
| Document: tm2625311d1_6k.htm | 0001104659-26-107117 |
| Document: 0001104659-26-107117-index-headers.html | 0001104659-26-107117 |
| Document: 0001104659-26-107117-index.html | 0001104659-26-107117 |
| Document: 0001104659-26-107117.txt | 0001104659-26-107117 |
| 6-K Filing (AGMB) — Batch item 6 | 0001104659-26-107117 |
| Document: tm2625311d1_6k.htm | 0001104659-26-107117 |
| Document: 0001104659-26-107117-index-headers.html | 0001104659-26-107117 |
| Document: 0001104659-26-107117-index.html | 0001104659-26-107117 |
| Document: 0001104659-26-107117.txt | 0001104659-26-107117 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Insider Buy | $9.26 | awaiting T+5 | — | $9.05 (−2.27%) |
Oct 13, 2026 13d ago | 6-K | $8.69 $9.11 | ▲ +4.83% | ▲ +4.38% | $9.05 (+4.14%) |
Oct 13, 2026 13d ago | Press Release | $8.69 $9.11 | ▲ +4.83% | ▲ +4.38% | $9.05 (+4.14%) |
Oct 1, 2026 25d ago | 6-K | $8.65 $9.22 | ▲ +6.59% | ▲ +5.29% | $9.05 (+4.62%) |
Oct 1, 2026 25d ago | Press Release | $8.65 $9.22 | ▲ +6.59% | ▲ +5.29% | $9.05 (+4.62%) |
Sep 14, 2026 6w ago | 6-K | $12.16 $11.49 | ▼ −5.51% | ▼ −7.64% | $9.05 (−25.58%) |
Sep 14, 2026 6w ago | Press Release | $12.16 $11.49 | ▼ −5.51% | ▼ −7.64% | $9.05 (−25.58%) |
Sep 11, 2026 6w ago | 6-K | $12.28 $11.70 | ▼ −4.72% | ▼ −4.83% | $9.05 (−26.30%) |
Aug 10, 2026 11w ago | 6-K | $14.85 $13.73 | ▼ −7.54% | ▼ −7.14% | $9.05 (−39.06%) |
Jun 23, 2026 17w ago | 6-K | $12.68 $11.87 | ▼ −6.39% | ▼ −8.10% | $9.05 (−28.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers